Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Acutus Medical, Inc. stock logo
AFIB
Acutus Medical
$0.00
$0.00
$0.00
$0.01
$6K5.686,997 shsN/A
GMVDF
G Medical Innovations
$0.00
$0.00
$0.03
$26K27.2815,560 shsN/A
T2 Biosystems, Inc. stock logo
TTOO
T2 Biosystems
$0.00
$0.00
$0.00
$0.16
$8K7.89,744 shs1,066 shs
VRAYQ
ViewRay
$0.00
$0.00
$0.00
$18K0.919,400 shsN/A
The Next 7 Blockbuster Stocks for Growth Investors Cover

Wondering what the next stocks will be that hit it big, with solid fundamentals? Click the link to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Acutus Medical, Inc. stock logo
AFIB
Acutus Medical
0.00%+100.00%+100.00%+100.00%-88.89%
GMVDF
G Medical Innovations
0.00%0.00%0.00%0.00%0.00%
T2 Biosystems, Inc. stock logo
TTOO
T2 Biosystems
0.00%-80.00%-50.00%+300.00%-99.71%
VRAYQ
ViewRay
0.00%0.00%0.00%0.00%-2.91%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Acutus Medical, Inc. stock logo
AFIB
Acutus Medical
$0.00
$0.00
$0.00
$0.01
$6K5.686,997 shsN/A
GMVDF
G Medical Innovations
$0.00
$0.00
$0.03
$26K27.2815,560 shsN/A
T2 Biosystems, Inc. stock logo
TTOO
T2 Biosystems
$0.00
$0.00
$0.00
$0.16
$8K7.89,744 shs1,066 shs
VRAYQ
ViewRay
$0.00
$0.00
$0.00
$18K0.919,400 shsN/A
The Next 7 Blockbuster Stocks for Growth Investors Cover

Wondering what the next stocks will be that hit it big, with solid fundamentals? Click the link to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Acutus Medical, Inc. stock logo
AFIB
Acutus Medical
0.00%+100.00%+100.00%+100.00%-88.89%
GMVDF
G Medical Innovations
0.00%0.00%0.00%0.00%0.00%
T2 Biosystems, Inc. stock logo
TTOO
T2 Biosystems
0.00%-80.00%-50.00%+300.00%-99.71%
VRAYQ
ViewRay
0.00%0.00%0.00%0.00%-2.91%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Acutus Medical, Inc. stock logo
AFIB
Acutus Medical
0.00
N/AN/AN/A
GMVDF
G Medical Innovations
0.00
N/AN/AN/A
T2 Biosystems, Inc. stock logo
TTOO
T2 Biosystems
0.00
N/AN/AN/A
VRAYQ
ViewRay
0.00
N/AN/AN/A
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Acutus Medical, Inc. stock logo
AFIB
Acutus Medical
$7.16M0.00N/AN/A($0.03) per share-0.01
GMVDF
G Medical Innovations
$4.42M0.00N/AN/AN/ANaN
T2 Biosystems, Inc. stock logo
TTOO
T2 Biosystems
$7.68M0.00N/AN/A($6.91) per share0.00
VRAYQ
ViewRay
$102.21M0.00N/AN/AN/ANaN
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Acutus Medical, Inc. stock logo
AFIB
Acutus Medical
-$81.66M-$0.11N/AN/AN/A-272.74%-311.64%-11.57%8/7/2026 (Estimated)
GMVDF
G Medical Innovations
-$24.63MN/AN/AN/AN/AN/AN/AN/AN/A
T2 Biosystems, Inc. stock logo
TTOO
T2 Biosystems
-$50.08M-$3.89N/AN/AN/A-563.16%N/A-174.06%7/28/2026 (Estimated)
VRAYQ
ViewRay
-$107.33M-$0.31N/AN/AN/AN/AN/AN/AN/A
CompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive Growth
Acutus Medical, Inc. stock logo
AFIB
Acutus Medical
N/AN/AN/AN/AN/A
GMVDF
G Medical Innovations
N/AN/AN/AN/AN/A
T2 Biosystems, Inc. stock logo
TTOO
T2 Biosystems
N/AN/AN/AN/AN/A
VRAYQ
ViewRay
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Acutus Medical, Inc. stock logo
AFIB
Acutus Medical
N/A
1.85
1.57
GMVDF
G Medical Innovations
N/AN/AN/A
T2 Biosystems, Inc. stock logo
TTOO
T2 Biosystems
N/A
0.40
0.24
VRAYQ
ViewRay
N/AN/AN/A

Institutional Ownership

CompanyInstitutional Ownership
Acutus Medical, Inc. stock logo
AFIB
Acutus Medical
56.91%
GMVDF
G Medical Innovations
5.96%
T2 Biosystems, Inc. stock logo
TTOO
T2 Biosystems
23.18%
VRAYQ
ViewRay
15.47%

Insider Ownership

CompanyInsider Ownership
Acutus Medical, Inc. stock logo
AFIB
Acutus Medical
5.21%
GMVDF
G Medical Innovations
37.10%
T2 Biosystems, Inc. stock logo
TTOO
T2 Biosystems
0.03%
VRAYQ
ViewRay
2.50%
CompanyEmployeesShares OutstandingFree FloatOptionable
Acutus Medical, Inc. stock logo
AFIB
Acutus Medical
34029.91 million28.23 millionOptionable
GMVDF
G Medical Innovations
72259.92 million163.49 millionNot Optionable
T2 Biosystems, Inc. stock logo
TTOO
T2 Biosystems
18021.04 million21.04 millionNo Data
VRAYQ
ViewRay
300183.40 million178.82 millionNo Data

Recent News About These Companies

No headlines for this company have been tracked by MarketBeat.com

New MarketBeat Followers Over Time

Media Sentiment Over Time

Acutus Medical stock logo

Acutus Medical NASDAQ:AFIB

$0.0002 0.00 (0.00%)
As of 06/16/2026

Acutus Medical, Inc. designs, manufactures, and markets various tools for catheter-based ablation procedures to treat various arrhythmias in the United States and internationally. Its product portfolio includes novel access sheaths, transseptal crossing tools, diagnostic and mapping catheters, conventional and contact ablation catheters, and mapping and imaging consoles and accessories, as well as supporting algorithms and software programs. Acutus Medical, Inc. was incorporated in 2011 and is headquartered in Carlsbad, California.

G Medical Innovations NASDAQ:GMVDF

G Medical Innovations Holdings Ltd, together with its subsidiaries, an early commercial stage healthcare company, engages in the development of next generation mobile health and telemedicine solutions in the United States, China, and Israel. The company's products include Prizma, a plug-and-play medical device that measures vital signs with electronic medical records functionality and clinical grade reporting standards; and Extended Holter Patch System, a multi-channel patient-worn biosensor that captures ECG data continuously for up to 14 days. It develops Wireless Vital Signs Monitoring System, a solution that provides continuous real time monitoring of vital signs and biometrics. In addition, it offers monitoring services, including independent diagnostic testing facility monitoring and private monitoring services. G Medical Innovations Holdings Ltd was incorporated in 2014 and is headquartered in Rehovot, Israel.

T2 Biosystems stock logo

T2 Biosystems NASDAQ:TTOO

$0.0004 0.00 (0.00%)
As of 01:29 PM Eastern

T2 Biosystems, Inc., an in vitro diagnostics company, develops and sells diagnostic products and product candidates in the United States and internationally. Its technology enables detection of pathogens, biomarkers, and other abnormalities in various unpurified patient sample types, including whole blood, plasma, serum, saliva, sputum, cerebral spinal fluid, and urine. The company also offers T2Dx Instrument, a bench-top instrument that runs various diagnostic tests from patient samples; T2Candida panel, a direct-from-blood molecular diagnostic test panel that detects lethal form of common blood stream infections, which cause sepsis and candidemia; T2Bacteria panel, a direct-from-blood molecular diagnostic test panel, which detects bacterial pathogens in blood stream infections; T2Resistance panel, a direct-from-blood test that identifies carbapenem resistance genes; and T2Biothreat, a direct-from-blood molecular diagnostic test panel that runs on the T2Dx Instrument and detects biothreat pathogens. In addition, it is developing T2Cauris panel, a direct-from-blood molecular diagnostic test that runs on the T2Dx Instrument and detects Candida auris; and T2Lyme panel, a direct-from-blood molecular diagnostic test panel that runs on the T2Dx Instrument to identify the bacteria that cause Lyme disease. T2 Biosystems, Inc. was incorporated in 2006 and is headquartered in Lexington, Massachusetts.

ViewRay NASDAQ:VRAYQ

ViewRay, Inc. designs, manufactures, and markets magnetic resonance imaging (MRI) guided radiation therapy systems to image and treat cancer patients in the United States, Italy, France, Taiwan, the United Kingdom, and internationally. It provides MRIdian, which is an MRI guided radiation therapy system that addresses beam distortion, skin toxicity, and other concerns. The company serves university research and teaching hospitals, community hospitals, private practices, government institutions, and freestanding cancer centers through a network of direct sales force and distributors. ViewRay, Inc. was founded in 2004 and is headquartered in Denver, Colorado. On July 16, 2023, ViewRay, Inc., alongwith its affiliate, filed a voluntary petition for reorganization under Chapter 11 in the U.S. Bankruptcy Court for the District of Delaware. On October 26, 2023, the voluntary petition of ViewRay , Inc. for reorganization under Chapter 11 was converted to Chapter 7. It had filed for Chapter 11 bankruptcy on July 16, 2023.